Why Invest in the Southeast? In sum, because the region’s dynamic and growing economy produces strong deal flow at reasonable valuations, and has historically produced higher returns for venture investors than other regions of the country. The Southeastern economy...Read More
G1 Therapeutics, a biotechnology startup in Research Triangle Park, N.C., said Wednesday it raised $47 million in venture capital funding that will allow it to continue developing two cancer drugs.read more
We return to Florida in 2016, holding the meeting in Jacksonville, FL at the beautiful Hyatt Regency Riverfront Jacksonville. Please click on the logo above, for further information.
Looking forward to seeing you there!!read more
Arbor Pharmaceuticals, LLC and XenoPort, Inc. announced today that they have signed a definitive agreement under which Arbor will acquire XenoPort for $7.03 per share in cash, or a total equity value of approximately $467 million.read more